EUVIMEDEUVIMED entdecken
Crossref

Grade 4 myelosuppression following the first chemotherapy in newly diagnosed lymphomas: results of a prospective study with a long-term follow-up

Weili Xue, Zhuling Liu, Yue Song, Hui Yu, Yu Chang, Feifei Nan, Yaqing Li, Xudong Zhang, Lei Zhang, Tiantian Zhang, Mingzhi Zhang

Medical Oncology · 20.11.2026 · 43 (12)

DOI: 10.1007/s12032-026-03574-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medical Oncology, online erschienen am 20.11.2026. Verfasst von Weili Xue und 10 weiteren Autor:innen. Die Arbeit nennt 29 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Xue, W., Liu, Z., Song, Y., Yu, H., Chang, Y., Nan, F., Li, Y., Zhang, X., Zhang, L., Zhang, T., & Zhang, M. (2026). Grade 4 myelosuppression following the first chemotherapy in newly diagnosed lymphomas: results of a prospective study with a long-term follow-up. Medical Oncology, 43(12). https://doi.org/10.1007/s12032-026-03574-2

Vancouver

Xue W, Liu Z, Song Y, Yu H, Chang Y, Nan F, et al. Grade 4 myelosuppression following the first chemotherapy in newly diagnosed lymphomas: results of a prospective study with a long-term follow-up. Medical Oncology. 2026;43(12). doi:10.1007/s12032-026-03574-2

BibTeX
@article{Xue2026,
  author = {Xue, Weili and Liu, Zhuling and Song, Yue and Yu, Hui and Chang, Yu and Nan, Feifei and Li, Yaqing and Zhang, Xudong and Zhang, Lei and Zhang, Tiantian and Zhang, Mingzhi},
  title = {Grade 4 myelosuppression following the first chemotherapy in newly diagnosed lymphomas: results of a prospective study with a long-term follow-up},
  journal = {Medical Oncology},
  year = {2026},
  volume = {43},
  number = {12},
  doi = {10.1007/s12032-026-03574-2}
}
Kostenlos starten →